ALK and inflammatory myofibroblastic tumor: Although recent advancements in pathologists’ recognition of IMT morphology and the application of anaplastic lymphoma kinase (ALK) immunohistochemistry and molecular testing have improved diagnostic accuracy, identifying atypical variants such as ALK-negative and uncommon histopathological characteristics of IMTs remain challenging.